Pfizer Covid Pill Cleared for High-Risk Patients in U.S. (2)

Pfizer Inc.’s Covid-19 pill gained clearance for emergency use in the U.S., delivering a more convenient treatment option for at-risk patients at a critical point in the pandemic.

The drug, called Paxlovid, is the first at-home therapy for Covid-19 to win clearance from the Food and Drug Administration. It is expected to become a potent weapon in battling the virus once production gears up, giving people at high risk of severe complications from the disease a way to avoid winding up in the hospital.

“This authorization provides a new tool to combat Covid-19 at a crucial time in the ...